NO986112L - Steroide bisfosfonater - Google Patents

Steroide bisfosfonater

Info

Publication number
NO986112L
NO986112L NO986112A NO986112A NO986112L NO 986112 L NO986112 L NO 986112L NO 986112 A NO986112 A NO 986112A NO 986112 A NO986112 A NO 986112A NO 986112 L NO986112 L NO 986112L
Authority
NO
Norway
Prior art keywords
group
derivatives
bisphosphonates
steroidal
hydroxy
Prior art date
Application number
NO986112A
Other languages
English (en)
Norwegian (no)
Other versions
NO986112D0 (no
Inventor
James Anthony Gallagher
Jonathan Paul Granville Moore
Wayne Barry Bowler
Philip Charles Bulman
Original Assignee
Univ Liverpool
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Liverpool filed Critical Univ Liverpool
Publication of NO986112D0 publication Critical patent/NO986112D0/no
Publication of NO986112L publication Critical patent/NO986112L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J51/00Normal steroids with unmodified cyclopenta(a)hydrophenanthrene skeleton not provided for in groups C07J1/00 - C07J43/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A61K47/548Phosphates or phosphonates, e.g. bone-seeking

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO986112A 1996-06-28 1998-12-23 Steroide bisfosfonater NO986112L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9613722.9A GB9613722D0 (en) 1996-06-28 1996-06-28 Chemical compounds
PCT/GB1997/001748 WO1998000438A1 (en) 1996-06-28 1997-06-26 Steroid bisphosphonates

Publications (2)

Publication Number Publication Date
NO986112D0 NO986112D0 (no) 1998-12-23
NO986112L true NO986112L (no) 1999-02-23

Family

ID=10796129

Family Applications (1)

Application Number Title Priority Date Filing Date
NO986112A NO986112L (no) 1996-06-28 1998-12-23 Steroide bisfosfonater

Country Status (23)

Country Link
US (1) US6140518A (zh)
EP (1) EP0912598A1 (zh)
JP (1) JP2000513372A (zh)
KR (1) KR20000022262A (zh)
CN (1) CN1226253A (zh)
AP (1) AP9801431A0 (zh)
AU (1) AU3350697A (zh)
BG (1) BG103123A (zh)
BR (1) BR9710074A (zh)
CA (1) CA2259309A1 (zh)
CZ (1) CZ432398A3 (zh)
EE (1) EE9800454A (zh)
GB (1) GB9613722D0 (zh)
HU (1) HUP9902880A3 (zh)
IL (1) IL127781A0 (zh)
IS (1) IS4931A (zh)
NO (1) NO986112L (zh)
PL (1) PL330781A1 (zh)
SK (1) SK175198A3 (zh)
TR (1) TR199900490T2 (zh)
WO (1) WO1998000438A1 (zh)
YU (1) YU59898A (zh)
ZA (1) ZA975749B (zh)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8586781B2 (en) 1998-04-02 2013-11-19 Mbc Pharma, Inc. Bone targeted therapeutics and methods of making and using the same
US7598246B2 (en) * 1998-04-02 2009-10-06 Mbc Pharma, Inc. Bisphosphonate conjugates and methods of making and using the same
US6896871B2 (en) 1998-04-02 2005-05-24 Mbc Research, Inc. Biphosphonate conjugates and methods of making and using the same
ATE451382T1 (de) 1999-01-20 2009-12-15 Takara Bio Inc 4-substituierte-3,6-anhydro-galaktosederivate und ihre pharmazeutische verwendung
AU781068B2 (en) * 1999-08-19 2005-05-05 Sydney Children's Hospitals Network (Randwick and Westmead) (incorporating The Royal Alexandra Hospital for Children), The Drug for treating fractures
AUPQ232599A0 (en) * 1999-08-19 1999-09-09 Royal Alexandra Hospital For Children, The Drug for treating fractures
US6436386B1 (en) 2000-11-14 2002-08-20 Shearwater Corporation Hydroxyapatite-targeting poly (ethylene glycol) and related polymers
US7829074B2 (en) 2001-10-18 2010-11-09 Nektar Therapeutics Hydroxypatite-targeting poly(ethylene glycol) and related polymers
CA2443857C (en) * 2001-04-10 2012-06-26 Mbc Research, Inc. Bisphosphonate conjugates and methods of making and using the same
EA200401565A1 (ru) * 2002-05-24 2005-04-28 Неофарм, Инк. Способ получения кардиолипина или аналога кардиолипина (варианты), способ получения липосомы и композиция кардиолипина для лечения заболеваний (варианты)
JP2006518701A (ja) * 2002-05-24 2006-08-17 ネオファーム、インコーポレイティッド カルジオリピン組成物、その製造方法及び使用
US20050277611A1 (en) * 2002-10-16 2005-12-15 Neopharm, Inc. Cationic cardiolipin analoges and its use thereof
US20060078560A1 (en) * 2003-06-23 2006-04-13 Neopharm, Inc. Method of inducing apoptosis and inhibiting cardiolipin synthesis
FI20070244A0 (fi) 2007-03-23 2007-03-23 Metso Paper Inc Tela
CN101835496B (zh) 2007-10-23 2015-11-25 尼克塔治疗公司 靶向羟基磷灰石的多臂聚合物以及由其制造的偶联物
EP2739154B1 (en) 2011-08-01 2018-06-27 MBC Pharma, Inc. Vitamin b6 derivatives of nucleotides, acyclonucleotides and acyclonucleoside phosphonates
EP2750711A2 (en) * 2011-08-31 2014-07-09 Mallinckrodt LLC Remote assembly of targeted nanoparticles using h-phosphonate-ene/-yne hydrophosphonylation reactions
WO2017079260A1 (en) * 2015-11-02 2017-05-11 University Of Rochester Phosphonate-chloroquine conjugates and methods using same

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4029499A1 (de) * 1990-09-18 1992-03-19 Boehringer Mannheim Gmbh Neue 17-(beta)-oestradiolderivate, verfahren zu deren herstellung und diese verbindungen enthaltende arzneimittel
EP0496520A1 (en) * 1991-01-22 1992-07-29 Merck & Co. Inc. Novel bone acting agents
FR2683527A1 (fr) * 1991-11-12 1993-05-14 Bretagne Occidentale Universit Prodrogues gem-bisphosphonates de sterouides derives de la cortisone.
JP3141053B2 (ja) * 1991-12-26 2001-03-05 アベンティス ファーマ株式会社 ビスホスホン酸誘導体
JP2746041B2 (ja) * 1992-02-14 1998-04-28 三菱化学株式会社 新規なステロイド誘導体

Also Published As

Publication number Publication date
IL127781A0 (en) 1999-10-28
KR20000022262A (ko) 2000-04-25
CA2259309A1 (en) 1998-01-08
BG103123A (en) 1999-10-29
CZ432398A3 (cs) 1999-05-12
NO986112D0 (no) 1998-12-23
AU3350697A (en) 1998-01-21
PL330781A1 (en) 1999-06-07
TR199900490T2 (xx) 1999-05-21
HUP9902880A3 (en) 2001-09-28
CN1226253A (zh) 1999-08-18
GB9613722D0 (en) 1996-08-28
US6140518A (en) 2000-10-31
BR9710074A (pt) 2000-01-18
YU59898A (en) 1999-11-22
JP2000513372A (ja) 2000-10-10
EP0912598A1 (en) 1999-05-06
WO1998000438A1 (en) 1998-01-08
SK175198A3 (en) 1999-06-11
IS4931A (is) 1998-12-22
AP9801431A0 (en) 1998-12-31
ZA975749B (en) 1998-07-27
EE9800454A (et) 1999-06-15
HUP9902880A2 (hu) 2000-03-28

Similar Documents

Publication Publication Date Title
NO986112L (no) Steroide bisfosfonater
NO20065573L (no) Orto-substituerte aryl eller heteroarylamidforbindelser
NO20065578L (no) Substituerte metylaryl eller heteroarylamidforbindelser
NO993868L (no) 3-piperidyl-4-oksokinazolinderivater og farmasöytiske preparater omfattende samme
NO20062617L (no) Anvendelse av glukosidase inhibitorer for terapi av mucovisidose
AU666916B2 (en) Novel 19-nor steroids having a thiocarbon-containing chain in the 11beta position, a method for preparing same and intermediates therefor, medicinal uses thereof and compositions containing said steroids
EA199700351A1 (ru) Пентациклическое соединение
AU2148295A (en) 22-thiavitamin d3 derivative
ATE177751T1 (de) Delta 16 ungesättigtes c17 heterocyclische steroide zur verwendung als steroid c17-20 lyase inhibitoren
EP0879841A3 (en) Silicon compound, method for making the same, and electroluminescent device using the same
Farrington et al. Design and Synthesis of new transition-state analog inhibitors of aspartate transcarbamylase
NO933885L (no) gsmåte
BR0014615A (pt) Derivado de ácido fosfÈnico que apresenta atividade inibidora contra carboxipeptidase b
NO20050292L (no) Acyloksypyrrolidinderivater og anvendelse derav som ligander av V1B eller bade V1Bog V1A reseptorer
ATE127123T1 (de) Biphosphonsäurederivate, produktion und verwendung davon.
NO903475D0 (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme estere av organiske syrer og alkoholer avledet fra 19-nor-steroider og deres salter.
AU3285000A (en) 22r-hydroxycholesta-8,14-diene derivatives for the inhibition of meiosis
AU2003226456A1 (en) Ptx3 gene expression suppressing method
AU8112798A (en) Novel n-benzenesulphonyl-l-proline compounds, preparation method and use in therapy
MX9604735A (es) Derivados de la 22-tiavitamina d3.
TW345487B (en) Composition for controlling noxious insects and/or mites comprising an ester compound
NO934791L (no) Cefalosporinsalter og fremgangsmåte for fremstilling derav
HUP0102089A2 (hu) Eljárás nitro-guanidin-származékok előállítására
AU5044499A (en) 2-ethyl-2,3-dihydrobenzofuran-carboxylic acid ester derivative, preparation method and use for preparing efaroxan derivatives
TW343976B (en) 17-substituted steroids useful in cancer treatment

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application